New York, NY – Deborah Yurgelun-Todd, Ph.D., director of the Cognitive Neuroimaging and Neuropsychology Laboratories at the McLean Hospital Brain Imaging Center and associate professor of Psychiatry at Harvard Medical School, will present "Oral Cognizin® Citicoline Supplementation Increases Brain Cellular Bioenergetics" at the International Society of Sports Nutrition Annual Conference in New Orleans on Tuesday, June 16.
Cognizin® brand Citicoline is a natural water-soluble compound that enhances communication between neurons in the brain to support visual function and protect neural structures from free radical damage. New research from Harvard shows Citicoline increases energy (ATP) levels in the brain, increasing one's ability to focus, concentrate and generally be more productive.
The most recent trial studied the effect of Cognizin® on healthy middle-aged adults. Using the latest brain scanning technology, Yurgelun-Todd and her team of researchers at the Harvard-associated Brain Imaging Center at McLean Hospital in Boston, observed increases in brain activity among people who had taken Cognizin® brand Citicoline for six weeks, particularly when individuals performed tasks that required sustained attention or memory.
Because Cognizin® helps make more energy available to brain cells they are better able to perform their daily tasks. Cell membranes are synthesized and maintained. Vital brain nutrients are produced and electrical impulses are generated.
The maker of the branded ingredients Cognizin® Citicoline, Hydrafend™ Hyaluronic Acid, Lumistor® L-Hydroxyproline, Kyowa CoQ10®, Setria® Glutathione and Sustamine™ Alanyl Glutamine, Kyowa offers manufacturers and formulators one of the industry's most extensive lines of over 50 amino acids and related compounds, including D-Amino acids and branch-chain amino acids, as well as nucleic acids, bio-products and fine chemicals.